The latest, updated COVID-19 vaccines should soon be available to everyone and offered largely ... the company said. A new COVID-19 booster from Moderna shows promising results for protecting against ...
To evaluate the effectiveness of the booster ... two shots of Moderna. Several foreigners traveled to the U.S. at the beginning of the pandemic when vaccines were not widely available and chose ...
The 437-patient study – reported in June – compared a 50 µg booster dose of both ... Bivalent Original/Omicron available to the UK public," said Moderna in a statement. The company added ...
The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...
Germany's campaign will use Pfizer/BioNTech and Moderna ... start a booster campaign, although France's President Emmanuel Macon has also suggested that third doses would be made available to ...
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
Stocktwits on MSN4h
Moderna’s Q4 Losses Worse Than Feared, But Revenue Beat And Cost Cuts Boost Stock — Retail Sentiment FollowsModerna, Inc. (MRNA) shares were up over 3% in choppy trading on Friday afternoon, even as the biotech firm reported a ...
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...
As public health officials monitor a rise in U.S. measles cases, some may be wondering if they need a booster vaccine to ...
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry ...
It's unclear how he will impact biotech stocks. Evaluate the expected performance of Moderna (MRNA) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback